General Information
Version
8.6
Revision date
2024-11-21
Product name
Chondrocyte cell line C28/I2
1.2.1 Relevant identified uses
Reagent for development and research
Emergency telephone
+56 2 2581 4934, +56 2 2 2473600, +56 2 2 6353800
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
none
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Labelling
Hazard pictograms
none
Signal word
none
Hazard statements
none EUH210 Safety data sheet available on request. EUH208
Precautionary statements
none
Supplemental label elements
none
Contains
penicillin G sodium salt (1 1). May produce an allergic reaction.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Although the cell lines are not known to contain any agents capable of harm humans the possibility of a contaminant, adventitious virus can rarely be excluded. Therefore, it is recommended that all animal / human cell lines are handled at Biosafety Level 2 containment [United States Government Publication "Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition" (CDC, 2009).] Human source: Appropriate safety procedure must be followed for human source material as found in: Laboratory Biosafety Guidelines, 3rd edition, 2004.
